UBS O'Connor’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
Sell
-7,773
Closed -$519K 415
2016
Q1
$519K Buy
+7,773
New +$519K 0.01% 346